If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Annalisa Perna is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 34 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome

Galbusera, M., Noris, M., Gastoldi, S., Bresin, E., Mele, C., Breno, M., Cuccarolo, P., Alberti, M., Valoti, E., Piras, R., Donadelli, R., Vivarelli, M., Murer, L., Pecoraro, C., Ferrari, E., Perna, A., Benigni, A., Portalupi, V. & Remuzzi, G., Mar 6 2019, In : American Journal of Kidney Diseases.

Research output: Contribution to journalArticle

  • An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome

    Galbusera, M., Noris, M., Gastoldi, S., Bresin, E., Mele, C., Breno, M., Cuccarolo, P., Alberti, M., Valoti, E., Piras, R., Donadelli, R., Vivarelli, M., Murer, L., Pecoraro, C., Ferrari, E., Perna, A., Benigni, A., Portalupi, V. & Remuzzi, G., Mar 6 2019, In : American Journal of Kidney Diseases. p. 56-72

    Research output: Contribution to journalArticle

    A thoracic pain of difficult diagnosis. Unusual localization of osteoid osteoma

    XIX CONGRESSO NAZIONALE S.I.C.O.O.P. SOCIETA' ITALIANA CHIRURGHI ORTOPEDICI DELL'OSPEDALITA' PRIVATA ACCREDITATA, Apr 2019, In : Journal of Biological Regulators and Homeostatic Agents. 33, 2 Suppl. 1, p. 141-145 5 p.

    Research output: Contribution to journalArticle

  • Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial

    ANSWER Study Organization, Sep 2019, In : American Journal of Kidney Diseases. 74, 3, p. 338-350 13 p.

    Research output: Contribution to journalArticle

  • Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial

    Organization, O. B. O. T. VALID. S., Ruggenenti, P., Trillini, M., P. Barlovic, D., Cortinovis, M., Pisani, A., Parvanova, A., Iliev, I. P., Ruggiero, B., Rota, S., Aparicio, M. C., Perna, A., Peraro, F., Diadei, O., Gaspari, F., Carrara, F., Stucchi, N., Martinetti, D., Janez, A., Gregoric, N. & 10 others, Riccio, E., Bossi, A. C., Trevisan, R., Manunta, P., Battaglia, G., David, S., Aucella, F., Belviso, A., Satta, A. & Remuzzi, G., May 1 2019, In : Diabetes, Obesity and Metabolism. 21, 5, p. 1177-1190 14 p.

    Research output: Contribution to journalArticle